153 related articles for article (PubMed ID: 32243354)
21. Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma.
Ding C; Yi X; Wu X; Bu X; Wang D; Wu Z; Zhang G; Gu J; Kang D
Cancer Lett; 2020 Jun; 479():1-12. PubMed ID: 32194140
[TBL] [Abstract][Full Text] [Related]
22. MiR-3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway.
Kong S; Cao Y; Li X; Li Z; Xin Y; Meng Y
J Cell Mol Med; 2020 Apr; 24(8):4677-4686. PubMed ID: 32181582
[TBL] [Abstract][Full Text] [Related]
23. Methylation associated miR-1246 contributes to poor prognosis in gliomas treated with temozolomide.
Wang H; Wu B; Wang J; Hu Y; Dai X; Ye L; Cheng H
Clin Neurol Neurosurg; 2021 Jan; 200():106344. PubMed ID: 33153768
[TBL] [Abstract][Full Text] [Related]
24. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
[TBL] [Abstract][Full Text] [Related]
26. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
[TBL] [Abstract][Full Text] [Related]
27. Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2.
Yu L; Gui S; Liu Y; Qiu X; Zhang G; Zhang X; Pan J; Fan J; Qi S; Qiu B
Aging (Albany NY); 2019 Aug; 11(15):5300-5318. PubMed ID: 31386624
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-30e-3p inhibits glioma development and promotes drug sensitivity to temozolomide treatment via targeting canopy FGF signaling regulator 2.
Gao K; Wang T; Qiao Y; Cui B
Cell Cycle; 2021 Nov; 20(22):2361-2371. PubMed ID: 34657557
[TBL] [Abstract][Full Text] [Related]
29. LINC01198 promotes proliferation and temozolomide resistance in a NEDD4-1-dependent manner, repressing PTEN expression in glioma.
Chen WL; Chen HJ; Hou GQ; Zhang XH; Ge JW
Aging (Albany NY); 2019 Aug; 11(16):6053-6068. PubMed ID: 31469661
[TBL] [Abstract][Full Text] [Related]
30. Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis.
Zhang K; Fu G; Pan G; Li C; Shen L; Hu R; Zhu S; Chen Y; Cui H
Cell Death Dis; 2018 Oct; 9(10):1035. PubMed ID: 30305611
[TBL] [Abstract][Full Text] [Related]
31. LncRNA-XIST interacts with
Du P; Zhao H; Peng R; Liu Q; Yuan J; Peng G; Liao Y
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28831025
[TBL] [Abstract][Full Text] [Related]
32. LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis.
Li B; Zhao H; Song J; Wang F; Chen M
Hum Cell; 2020 Jan; 33(1):159-174. PubMed ID: 31713817
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-induced miR-497 decreases glioma cell sensitivity to TMZ by inhibiting apoptosis.
Lan J; Xue Y; Chen H; Zhao S; Wu Z; Fang J; Han C; Lou M
FEBS Lett; 2014 Sep; 588(18):3333-9. PubMed ID: 25080009
[TBL] [Abstract][Full Text] [Related]
34. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
Chen W; Yang Y; Chen B; Lu P; Zhan L; Yu Q; Cao K; Li Q
J Neurooncol; 2014 Oct; 120(1):43-53. PubMed ID: 25139024
[TBL] [Abstract][Full Text] [Related]
35. MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma.
Sun S; Wang X; Xu X; Di H; Du J; Xu B; Wang Q; Wang J
Oncotarget; 2017 Jan; 8(3):5057-5068. PubMed ID: 27926502
[TBL] [Abstract][Full Text] [Related]
36. Exosome-Mediated Transfer of circ-
Li G; Lan Q
Cancer Biother Radiopharm; 2023 Feb; 38(1):62-73. PubMed ID: 34762494
[No Abstract] [Full Text] [Related]
37. Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2.
Zhu D; Tu M; Zeng B; Cai L; Zheng W; Su Z; Yu Z
Cancer Med; 2017 Feb; 6(2):452-462. PubMed ID: 28064447
[TBL] [Abstract][Full Text] [Related]
38. FTO Inhibition Enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155/23a Cluster-MXI1 Feedback Circuit in Glioma.
Xiao L; Li X; Mu Z; Zhou J; Zhou P; Xie C; Jiang S
Cancer Res; 2020 Sep; 80(18):3945-3958. PubMed ID: 32680921
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.
Yang HC; Wang JY; Bu XY; Yang B; Wang BQ; Hu S; Yan ZY; Gao YS; Han SY; Qu MQ
J Cell Physiol; 2019 May; 234(5):6783-6800. PubMed ID: 30317578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
